CN101015599A - Composite Chinese medicine for treating pollen hypersensitivity symptom - Google Patents

Composite Chinese medicine for treating pollen hypersensitivity symptom Download PDF

Info

Publication number
CN101015599A
CN101015599A CN 200710034466 CN200710034466A CN101015599A CN 101015599 A CN101015599 A CN 101015599A CN 200710034466 CN200710034466 CN 200710034466 CN 200710034466 A CN200710034466 A CN 200710034466A CN 101015599 A CN101015599 A CN 101015599A
Authority
CN
China
Prior art keywords
chinese medicine
grams
pollen hypersensitivity
medicine composition
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 200710034466
Other languages
Chinese (zh)
Inventor
易树林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 200710034466 priority Critical patent/CN101015599A/en
Publication of CN101015599A publication Critical patent/CN101015599A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese medicinal composition for treating pollen hypersensitivity which mainly comprises the following components (by weight portion): astragalus root 1-3 part, pilose asiabell root 1-3 parts, root of Dahurain angelica 0.3-1 part, silver flower 0.3-1 part, mulberry leaf 0.3-1 parts. The composition can be used for improving humen immunocompetence and enhancing ability to fight diseases.

Description

A kind of Chinese medicine composition for the treatment of pollen hypersensitivity
Technical field
The invention belongs to Chinese medicine composition, be specifically related to a kind of Chinese medicine composition for the treatment of pollen hypersensitivity.
Background technology
Pollen hypersensitivity is meant respiratory tract and the irritated performance of eye that is caused by pollen hypersensitivity, also is a kind of anaphylaxis of specificity individuality to pollen, medically is called " nasal sinusitis " or " allergic rhinitis ".There is the diagnosis of what is called " pyretic cold " morning among the people in China, means in spring and summer season, and in the time of the weather sweltering heat, the symptom of respiratory tract may appear suddenly in patient, and this is early stage observation and the description of China to pollen hypersensitivity.At present, it is about 5%~10% that global pollen hypersensitivity prevalence has reached, and the patient of China is also increasing year by year.The symptom of pollen hypersensitivity is sneeze, rhinorrhea, drops tears, and itches in nose, eye and external ear Dodge, and severe patient also can bring out tracheitis, bronchial asthma, pulmonary heart disease (multiple in summer and autumn).According to statistics, China urbanite sickness rate is about 0.9%, and popular district can reach about 5%.
For pollen hypersensitivity, the ideal medicine of inefficacy still both at home and abroad at present.Aspect Chinese medicine,, all be the method for taking the kidney invigorating cold relieving mainly with the prescribed treatment pollen hypersensitivity.Though these class methods are effective in cure, easily recurrence.Because the medicine of the kidney invigorating and cold relieving helps male sexuality, cause sexual life too much, will cause insufficiency of kidney-YANG like this, deficiency of kidney-QI causes human righteousness's weakness easily, and is just effective in cure at period in a medicine, and recurrence again can not tackle the problem at its root after the drug withdrawal.
Summary of the invention
The objective of the invention is provides a kind of good effect at above-mentioned situation, is difficult for the Chinese medicine composition of the treatment pollen hypersensitivity of recurrence.
The Chinese medicine composition of treatment pollen hypersensitivity of the present invention mainly is made up of the component of following weight portion:
Radix Astragali 1-3 part, Radix Codonopsis 1-3 part, Radix Angelicae Dahuricae 0.3-1 part, Flos Lonicerae 0.3-1 part, Folium Mori 0.3-1 part.
Be preferably: 2 parts of the Radixs Astragali, 2 parts of Radix Codonopsis, 0.5 part of the Radix Angelicae Dahuricae, 0.5 part of Flos Lonicerae, 0.5 part on Folium Mori.
The present invention can also increase the Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae Officinalis, Flos Chrysanthemi Indici to improve therapeutic effect on the basis of said components, its weight portion is:
Rhizoma Atractylodis Macrocephalae 0.5-1.5 part, Cortex Magnoliae Officinalis 0.5-1 part, Flos Chrysanthemi Indici 0.3-1 part
Be preferably: 1 part of the Rhizoma Atractylodis Macrocephalae, 0.7 part of Cortex Magnoliae Officinalis, 0.5 part of Flos Chrysanthemi Indici.
The effect of each component in this compositions: Radix Codonopsis nature and flavor, sweet flat, invigorating the spleen and replenishing QI; Radix Astragali nature and flavor, Gan Wen, tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, toxin expelling evacuation of pus, diuretic detumescent; Rhizoma Atractylodis Macrocephalae nature and flavor, hardship, Gan Wen, invigorating the spleen and replenishing QI, dampness diuretic, strengthening superficial resistance to stop perspiration; The Folium Mori nature and flavor, sweetness and bitterness, cold, wind and heat dispersing, liver heat removing and eyesight improving; The Flos Lonicerae nature and flavor, sweet cold, heat-clearing and toxic substances removing; The Flos Chrysanthemi Indici nature and flavor, sweetness and bitterness, cold, heat-clearing and toxic substances removing; The Cortex Magnoliae Officinalis nature and flavor, toil temperature, removing dampness intestinal stasis relieving, circulation of qi promoting are relievingd asthma: Radix Angelicae Dahuricae nature and flavor, Xin Wen, deliver dispel the wind, clearing the nasal passage, reducing swelling and alleviating pain.
The inventor thinks through studying for a long period of time that according to theory of Chinese medical science " institute of heresy plays, and its gas must be empty " " healthy energy internal memory, heresy can not be done " pollen hypersensitivity is the positive deficiency of vital energy of the person, and susceptible ailment said due to cold or exposure institute extremely.So, should take to set upright gas, the heat of dispeling the wind just can be received excellent curative.Chinese medicine of the present invention is developed with regard to being based on this theory.
Preparation technology
The component of said ratio is pulverized → is mixed → add entry soak in right amount (2-3 hour) fry in shallow oil 2 hours → filter back → simmer down to extractum → oven dry → addings adjuvant → for smalls → compacting in flakes → bottle of packing into → seal → put the cool place drying to locate preservation.
Chinese medicine composition of the present invention is to adopt the pure natural plant medicine, ophthalmic pruritus, rhinocnesmus, runny nose or nasal obstruction, the sneeze that pollen hypersensitivity (allergic rhinitis) is caused, sheds tears very then eyelid swelled hyperemia, diseases such as chemosis.Chronic rhinitis, sinusitis, institute are caused diseases such as turbid nasal discharge, nasal obstruction also to have good curative effect.
Its major function and effect: benefiting vital QI and blood, expelling wind and dampness, clear the nasal passage, wind and heat dispersing detoxifcation.
This Chinese medicine composition can improve the human body self immunocompetence, increases resistance against diseases, prevention and treatment pollen hypersensitivity (allergic rhinitis) and the chronic rhinitis that causes, sinusitis and various symptom.This medication is imitated significantly, instant effect, short treating period (7-15 days), and taking convenience does not have any toxicity, takes the back disease and is difficult for recurrence.
The specific embodiment:
Embodiment 1
Get the Radix Astragali 30 grams, Radix Codonopsis 25 grams, the Radix Angelicae Dahuricae 8 grams, Flos Lonicerae 8 grams, Folium Mori 8 grams.
Embodiment 2
Get the Radix Astragali 20 grams, Radix Codonopsis 20 grams, the Radix Angelicae Dahuricae 5 grams, Flos Lonicerae 5 grams, Folium Mori 5 grams.
Embodiment 3
Get the Radix Astragali 25 grams, Radix Codonopsis 25 grams, the Radix Angelicae Dahuricae 4 grams, 4 parts of Flos Lonicerae, 4 parts on Folium Mori, the Rhizoma Atractylodis Macrocephalae 13 grams, Cortex Magnoliae Officinalis 10 grams, Flos Chrysanthemi Indici 8 grams.
Embodiment 4
Get the Radix Astragali 20 grams, Radix Codonopsis 20 grams, the Radix Angelicae Dahuricae 5 grams, Flos Lonicerae 5 grams, Folium Mori 5 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Cortex Magnoliae Officinalis 7 grams, Flos Chrysanthemi Indici 5 grams.
The component of each embodiment is made 0.5 tablet that restrains, oral three times of per day for adults, each three to five by aforementioned preparation technology respectively, the child is cut down according to the circumstance, obeying seven to 15 is a course of treatment, and pollen hypersensitivity is promptly had significant curative effect, obeys continuously and can consolidate no longer recurrence two courses of treatment.

Claims (4)

1, a kind of Chinese medicine composition for the treatment of pollen hypersensitivity is characterized in that mainly being made up of the component of following weight portion:
Radix Astragali 1-3 part, Radix Codonopsis 1-3 part, Radix Angelicae Dahuricae 0.3-1 part, Flos Lonicerae 0.3-1 part, Folium Mori 0.3-1 part.
2, Chinese medicine composition according to claim 1 is characterized in that each component adopts following weight portion:
2 parts of the Radixs Astragali, 2 parts of Radix Codonopsis, 0.5 part of the Radix Angelicae Dahuricae, 0.5 part of Flos Lonicerae, 0.5 part on Folium Mori.
3, Chinese medicine composition according to claim 1 is characterized in that also comprising in the component:
Rhizoma Atractylodis Macrocephalae 0.5-1.5 part, Cortex Magnoliae Officinalis 0.5-1 part, Flos Chrysanthemi Indici 0.3-1 part
4, Chinese medicine composition according to claim 3 is characterized in that each component adopts following weight portion:
1 part of the Rhizoma Atractylodis Macrocephalae, 0.7 part of Cortex Magnoliae Officinalis, 0.5 part of Flos Chrysanthemi Indici.
CN 200710034466 2007-02-16 2007-02-16 Composite Chinese medicine for treating pollen hypersensitivity symptom Pending CN101015599A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 200710034466 CN101015599A (en) 2007-02-16 2007-02-16 Composite Chinese medicine for treating pollen hypersensitivity symptom

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 200710034466 CN101015599A (en) 2007-02-16 2007-02-16 Composite Chinese medicine for treating pollen hypersensitivity symptom

Publications (1)

Publication Number Publication Date
CN101015599A true CN101015599A (en) 2007-08-15

Family

ID=38724926

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 200710034466 Pending CN101015599A (en) 2007-02-16 2007-02-16 Composite Chinese medicine for treating pollen hypersensitivity symptom

Country Status (1)

Country Link
CN (1) CN101015599A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101890079A (en) * 2010-04-29 2010-11-24 贵阳春科药业技术研发有限公司 Medical preparation for preventing and treating rhinitis and preparation method thereof
CN102920859A (en) * 2012-11-19 2013-02-13 高扬 Medicine for preventing pouen allergy
CN103028037A (en) * 2012-12-18 2013-04-10 张玉辉 Traditional Chinese medicine prescription for treating allergic rhinitis
CN103127383A (en) * 2013-02-21 2013-06-05 冯玉芳 Traditional Chinese medicine for treating children allergic rhinitis
CN103655878A (en) * 2012-09-11 2014-03-26 陈云玺 Medicine for curing acute and chronic nasosinusitis through anapnotherapy
CN111346206A (en) * 2020-03-17 2020-06-30 朱晓明 Perilla frutescens, ginger and ginseng tea and preparation method thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101890079A (en) * 2010-04-29 2010-11-24 贵阳春科药业技术研发有限公司 Medical preparation for preventing and treating rhinitis and preparation method thereof
CN101890079B (en) * 2010-04-29 2014-08-06 贵阳春科药业技术研发有限公司 Medical preparation for preventing and treating rhinitis and preparation method thereof
CN103655878A (en) * 2012-09-11 2014-03-26 陈云玺 Medicine for curing acute and chronic nasosinusitis through anapnotherapy
CN102920859A (en) * 2012-11-19 2013-02-13 高扬 Medicine for preventing pouen allergy
CN102920859B (en) * 2012-11-19 2014-02-19 高扬 Medicine for preventing pollen allergy
CN103028037A (en) * 2012-12-18 2013-04-10 张玉辉 Traditional Chinese medicine prescription for treating allergic rhinitis
CN103127383A (en) * 2013-02-21 2013-06-05 冯玉芳 Traditional Chinese medicine for treating children allergic rhinitis
CN111346206A (en) * 2020-03-17 2020-06-30 朱晓明 Perilla frutescens, ginger and ginseng tea and preparation method thereof

Similar Documents

Publication Publication Date Title
CN103463609B (en) The preparation method of the Chinese herbal oral decoction Chinese patent drug of the treatment infection of the upper respiratory tract
CN100355451C (en) Cold-treating influenza-preventing medicine
CN103920106A (en) Traditional Chinese medicinal composition for treating bronchitis and bronchial asthma
CN101015599A (en) Composite Chinese medicine for treating pollen hypersensitivity symptom
CN104069474A (en) Traditional Chinese medicine composition for treating seborrheic alopecia and preparation method thereof
CN101703686B (en) Chinese medicinal composition for treating diabetes
CN103071047B (en) Decoction for treating silicosis and preparation method thereof
CN102988649B (en) Medicament for treating chronic bronchitis and preparation method of medicament
CN103656276B (en) Medicine for the treatment of renal failure and preparation method thereof
CN104225339A (en) Chinese medicinal preparation for treating chronic pneumonia and preparation method
CN104524058A (en) Traditional Chinese medicine preparation for treating cerebral concussion and preparation method
WO2021103777A1 (en) Spraying agent for preventing and treating allergic asthma combined with allergic rhinitis in children and teenagers
CN105853562A (en) Pharmaceutical preparation for treating asthma and preparing method
CN103638513A (en) Pectoral syrup for tonifying spleen and nourishing stomach
CN103405671A (en) Traditional Chinese medicine for treating glaucoma caused by hyperactivity of liver-yang
CN1267143C (en) Method for preparing compound medicinal capsule and powder for nourishing yin
CN1305727A (en) Mixed ginseng tea
CN102430074B (en) Traditional Chinese medicine composite for treating chronic bronchitis
CN106266771A (en) A kind of Chinese medicine composition treating senile osteoporosis and preparation method thereof
CN104095124A (en) Herbal tea and preparation method thereof
CN104413196A (en) Enteromorpha anti-inflammation tea and preparation method thereof
CN104435853A (en) Traditional Chinese medicine composition for treating coronary heart disease
CN108114027A (en) A kind of new medicine composition for treating allergic rhinitis and preparation method
CN105194279A (en) Drug for treating dry eye syndrome
CN102178913B (en) Skin care pill for treating cold sensitive disease and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20070815